Sun Pharma gets DCGI approval for clinical trial with Nafamostat in Covid-19 patients

May 29, 2020

Mumbai (Maharashtra) [India], May 29 : Sun Pharmaceutical Industries said on Friday it has received approval from the Drugs Controller General of India (DCGI)...